FdaApplication

NDA 020392

Back to search

Identifiers

Properties

PropertyValue
applicant_nameMYLAN PHARMACEUTICALS INC
application_typeNDA
approval_date1994-08-15

Products (2)

ProductActive ingredientStrengthDosage form
CYSTAGONCYSTEAMINE BITARTRATEEQ 150MG BASECAPSULE;ORAL
CYSTAGONCYSTEAMINE BITARTRATEEQ 50MG BASECAPSULE;ORAL

2 products